Hopital de la croix rousse
Hopital de la croix rousse
Lyon, France3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Extension Study for the Port Delivery System With Ranibizumab (Portal) | Neovascular Age-Related Macular Degeneration | Recruiting | Phase 3 | 2026-09-28 | NCT03683251 | |
| A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome) | Neovascular Age-related Macular Degeneration (nAMD) | Active, not recruiting | Phase 3 | 2026-07-31 | NCT04657289 | |
| EGEA4 THE 30 YEAR FOLLOW UP OF THE EGEA STUDY | Healthy Volunteer EGEA4 Cohort | Recruiting | Not applicable | 2025-09-19 | NCT06334705 |